While numerous oncogenes have been identified as enhancers of tumor metastasis through the promotion of EMT, a subset of oncogenes, such as CREB1, MYC and FBXO22 (F-box protein 22), has been observed to concurrently facilitate proliferation while inhibiting EMT (Fig. 3). This evidence concerns the gene FBXO22 and neoplasm.